CA1065310A - Morpholine derivatives and production thereof - Google Patents
Morpholine derivatives and production thereofInfo
- Publication number
- CA1065310A CA1065310A CA242,957A CA242957A CA1065310A CA 1065310 A CA1065310 A CA 1065310A CA 242957 A CA242957 A CA 242957A CA 1065310 A CA1065310 A CA 1065310A
- Authority
- CA
- Canada
- Prior art keywords
- formula
- defined above
- compound
- give
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D267/02—Seven-membered rings
- C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D267/10—Seven-membered rings having the hetero atoms in positions 1 and 4 not condensed with other rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP454075A JPS5817469B2 (ja) | 1975-01-06 | 1975-01-06 | シンキナモルホリンユウドウタイノ シンキセイゾウホウ |
| JP6776775A JPS51143679A (en) | 1975-06-04 | 1975-06-04 | A new process for preparing novel morpholine derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1065310A true CA1065310A (en) | 1979-10-30 |
Family
ID=26338346
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA242,957A Expired CA1065310A (en) | 1975-01-06 | 1976-01-05 | Morpholine derivatives and production thereof |
Country Status (18)
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4169146A (en) * | 1975-01-06 | 1979-09-25 | Sumitomo Chemical Company, Limited | Novel morpholine derivatives and treating depression therewith |
| AU3364493A (en) * | 1992-01-28 | 1993-09-01 | Smithkline Beecham Plc | Compounds as calcium channel antagonists |
| US6214816B1 (en) * | 1998-03-17 | 2001-04-10 | Novo Nordisk A/S | Heterocyclic compounds |
| JP2002506863A (ja) * | 1998-03-17 | 2002-03-05 | ノボ ノルディスク アクティーゼルスカブ | 新規ヘテロ環式化合物 |
| US7294637B2 (en) | 2000-09-11 | 2007-11-13 | Sepracor, Inc. | Method of treating addiction or dependence using a ligand for a monamine receptor or transporter |
| AU2001290873B2 (en) | 2000-09-11 | 2006-07-27 | Sepracor Inc. | Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission) |
| TW200400816A (en) | 2002-06-26 | 2004-01-16 | Lilly Co Eli | Tricyclic steroid hormone nuclear receptor modulators |
-
1975
- 1975-12-30 FI FI753701A patent/FI753701A/fi not_active Application Discontinuation
- 1975-12-30 SE SE7514779A patent/SE7514779L/xx not_active Application Discontinuation
-
1976
- 1976-01-04 CS CS7636A patent/CS189735B2/cs unknown
- 1976-01-05 DK DK2476*#A patent/DK2476A/da not_active Application Discontinuation
- 1976-01-05 ES ES444101A patent/ES444101A1/es not_active Expired
- 1976-01-05 NO NO760018A patent/NO145197C/no unknown
- 1976-01-05 CH CH2176A patent/CH621781A5/de not_active IP Right Cessation
- 1976-01-05 PL PL1976186338A patent/PL98488B1/pl unknown
- 1976-01-05 CA CA242,957A patent/CA1065310A/en not_active Expired
- 1976-01-05 GB GB224/76A patent/GB1501321A/en not_active Expired
- 1976-01-05 FR FR7600106A patent/FR2296412A1/fr active Granted
- 1976-01-05 AR AR261847A patent/AR213280A1/es active
- 1976-01-05 AT AT2276A patent/AT346353B/de not_active IP Right Cessation
- 1976-01-05 AU AU10020/76A patent/AU498463B2/en not_active Expired
- 1976-01-06 US US05/646,908 patent/US4085210A/en not_active Expired - Lifetime
- 1976-01-06 NL NL7600096A patent/NL7600096A/xx not_active Application Discontinuation
- 1976-01-06 BE BE163339A patent/BE837341A/xx unknown
- 1976-01-07 DE DE19762600358 patent/DE2600358A1/de not_active Withdrawn
- 1976-09-28 AR AR264895A patent/AR212816A1/es active
-
1980
- 1980-07-29 CH CH579880A patent/CH623816A5/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CH621781A5 (US07655688-20100202-C00086.png) | 1981-02-27 |
| CH623816A5 (US07655688-20100202-C00086.png) | 1981-06-30 |
| AU498463B2 (en) | 1979-03-15 |
| FI753701A (US07655688-20100202-C00086.png) | 1976-07-07 |
| FR2296412A1 (fr) | 1976-07-30 |
| AR213280A1 (es) | 1979-01-15 |
| US4085210A (en) | 1978-04-18 |
| GB1501321A (en) | 1978-02-15 |
| FR2296412B1 (US07655688-20100202-C00086.png) | 1981-12-31 |
| AT346353B (de) | 1978-11-10 |
| AU1002076A (en) | 1977-07-14 |
| NO760018L (US07655688-20100202-C00086.png) | 1976-07-07 |
| BE837341A (fr) | 1976-07-06 |
| DK2476A (da) | 1976-07-07 |
| SE7514779L (sv) | 1976-07-07 |
| ES444101A1 (es) | 1977-07-16 |
| PL98488B1 (pl) | 1978-05-31 |
| DE2600358A1 (de) | 1976-07-08 |
| NL7600096A (nl) | 1976-07-08 |
| AR212816A1 (es) | 1978-10-13 |
| CS189735B2 (en) | 1979-04-30 |
| NO145197C (no) | 1982-02-03 |
| ATA2276A (de) | 1978-03-15 |
| NO145197B (no) | 1981-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4496557A (en) | Tricyclic ethers, their preparation and the pharmaceutical compositions containing them | |
| KR890001544B1 (ko) | 벤자제핀 유도체의 제조방법 | |
| US4113869A (en) | Tetrahydroisoquinoline basic ethers and pharmaceutical compositions and methods employing them | |
| NO161241B (no) | Anordning til bruk ved knelelignende sittestilling. | |
| HU198016B (en) | Process for producing benzene-condensed cycloalkan- and oxacycloalkan-trans-1,2-diamin derivatives and pharmaceutical compositions containing them | |
| CA1065310A (en) | Morpholine derivatives and production thereof | |
| US4478750A (en) | 1-Phenyl-azepinoindoles | |
| KR100213531B1 (ko) | 헥사히드로아제핀 유도체, 그것들의 제법과 그것들을 함유하는 약학 조성물 | |
| IE912499A1 (en) | Carbostyril derivatives | |
| IE46908B1 (en) | Pyridobenzodiazepines | |
| US3631039A (en) | 2-amino ethyl-2-hydroxy - 6-vinyl tetrahydropyrans tautomers and optical enantiomers thereof | |
| CA2155183A1 (en) | Morpholine derivative | |
| US3950425A (en) | Amino-substituted tetracyclic compounds | |
| US4169146A (en) | Novel morpholine derivatives and treating depression therewith | |
| US4045560A (en) | 2-Morpholine containing methano or ethano anthracene compounds | |
| CA1092113A (en) | Benzylamines | |
| US4017621A (en) | 2-Morpholinyl tricyclic dibenzazepine compounds | |
| EP0116373B1 (en) | 2h-(1) benzoxepino(5,4-b)-1,4-oxazine derivatives | |
| FI58127C (fi) | Foerfarande foer framstaellning av pao det centrala nervsystemet verkande pyridinodibensoazepin- oxazepin- -tiatzepin- och -diazepinderivat och deras salter | |
| US3988448A (en) | 1,4-Oxazepines as antidepressant agents | |
| US4062840A (en) | Amino-substituted 1,2,3,4-tetrahydro-9H-tribenzo[b,d,f]azepines | |
| EP0080117B1 (en) | The (r,r)-enantiomer of trans-indeno(1,2-b)-1,4-oxazines, process for its preparation and pharmaceutical formulation containing it | |
| FI66365B (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 1,4-cykloalkano-oxazepiner vari oxazepinringen och cykloalkanogruppen aer i cis-staellningen i foerhaollande till varandra | |
| US5212305A (en) | Process for preparing delmopinol via the intermediates isoxazolidines and isoxazolines | |
| US3716561A (en) | Selective allylic oxidation process |